INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2011

Dietary lipids and lipid oxidation products may modulate Alzheimer's disease pathophysiology.

This review summarizes recent findings regarding how dietary lipids modulate Alzheimer's disease (AD) development in animals and humans, focusing on lipid oxidation products. Oxidative breakdown products of omega-6 polyunsaturated fatty acids (PUFAs) and cholesterol (oxysterols) might promote beta-amyloid deposition, whereas omega-3 PUFAs appear to help prevent and treat AD, though high concentrations can also form oxidized derivatives. The authors suggest that maintaining an appropriate omega-3/omega-6 PUFA ratio, consuming healthy oils, fish, and antioxidants, and limiting cholesterol-containing foods may benefit clinical AD prevention strategies.

Study type
Narrative review
Who was studied
Humans and animals discussed in literature on Alzheimer's disease
What was measured
Alzheimer's disease development and pathogenetic role of lipid oxidation products

THE PAPER

Dietary lipids and their oxidized products in Alzheimer's disease.

Corsinovi L, Biasi F, Poli G, Leonarduzzi G, Isaia G. Mol Nutr Food Res, 2011.

PubMed 21954186 ↗DOI 10.1002/mnfr.201100208 ↗

Brain & moodHealthy aging & longevity

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.